Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
The original version of the published Article contained an incorrect citation for reference 20 “Hubbard, B. P. & Sinclair, D. A. Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay. Methods Mol. Biol. 1077, 167–177 (2013).” The citation for reference...
Guardado en:
Autores principales: | Ryan W. Dellinger, Santiago Roel Santos, Mark Morris, Mal Evans, Dan Alminana, Leonard Guarente, Eric Marcotulli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ad9d9e6d3a4470ca37aec031a9b1b39 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Ryan W. Dellinger, et al.
Publicado: (2017) -
Nicotinamide riboside kinase structures reveal new pathways to NAD+.
por: Wolfram Tempel, et al.
Publicado: (2007) -
NAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm −/− and old mice HSCs
por: Le Zong, et al.
Publicado: (2021) -
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Samuel A. J. Trammell, et al.
Publicado: (2016) -
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
por: Christopher R. Martens, et al.
Publicado: (2018)